메뉴 건너뛰기




Volumn 17, Issue 5, 2016, Pages 663-670

Longitudinal adverse event assessment in oncology clinical trials: The Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PLACEBO; VENLAFAXINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; FOLINIC ACID; PLATINUM COMPLEX;

EID: 84964326666     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)00038-3     Document Type: Article
Times cited : (87)

References (24)
  • 1
    • 84891646690 scopus 로고    scopus 로고
    • Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review
    • Peron J, Maillet D, Gan HK, Chen EX, You B Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. J Clin Oncol 2013, 31:3957-3963.
    • (2013) J Clin Oncol , vol.31 , pp. 3957-3963
    • Peron, J.1    Maillet, D.2    Gan, H.K.3    Chen, E.X.4    You, B.5
  • 2
    • 84894864108 scopus 로고    scopus 로고
    • Adverse event reporting in cancer clinical trial publications
    • Sivendran S, Latif A, McBride RB, et al. Adverse event reporting in cancer clinical trial publications. J Clin Oncol 2014, 32:83-89.
    • (2014) J Clin Oncol , vol.32 , pp. 83-89
    • Sivendran, S.1    Latif, A.2    McBride, R.B.3
  • 3
    • 0036513556 scopus 로고    scopus 로고
    • Assessment of toxicity in cooperative oncology clinical trials: the long and short of it
    • Gwede CK, Johnson DJ, Daniels SS, Trotti A Assessment of toxicity in cooperative oncology clinical trials: the long and short of it. J Oncol Manag 2002, 11:15-21.
    • (2002) J Oncol Manag , vol.11 , pp. 15-21
    • Gwede, C.K.1    Johnson, D.J.2    Daniels, S.S.3    Trotti, A.4
  • 4
    • 8744229000 scopus 로고    scopus 로고
    • Better reporting of groups in randomized trials: an extension of the CONSORT statement
    • Ioannidis JP, Evans SJ, Gotzsche PC, et al. Better reporting of groups in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004, 141:781-788.
    • (2004) Ann Intern Med , vol.141 , pp. 781-788
    • Ioannidis, J.P.1    Evans, S.J.2    Gotzsche, P.C.3
  • 6
    • 84944674953 scopus 로고    scopus 로고
    • The imperative for a new approach to toxicity analysis in oncology clinical trials
    • published online Aug 1.
    • Thanarajasingam G, Hubbard JM, Sloan JA, Grothey A The imperative for a new approach to toxicity analysis in oncology clinical trials. J Natl Cancer Inst 2015, published online Aug 1. 10.1093/jnci/djv216.
    • (2015) J Natl Cancer Inst
    • Thanarajasingam, G.1    Hubbard, J.M.2    Sloan, J.A.3    Grothey, A.4
  • 7
    • 34347218947 scopus 로고    scopus 로고
    • TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
    • Trotti A, Pajak TF, Gwede CK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 2007, 8:613-624.
    • (2007) Lancet Oncol , vol.8 , pp. 613-624
    • Trotti, A.1    Pajak, T.F.2    Gwede, C.K.3
  • 10
    • 0142184291 scopus 로고    scopus 로고
    • What happened to all the patients? Event charts for summarizing individual patient data and displaying clinically significant changes in quality of life data
    • Atherton PJ, Jasperson B, Nibbe A, et al. What happened to all the patients? Event charts for summarizing individual patient data and displaying clinically significant changes in quality of life data. Drug Info J 2003, 37:11-21.
    • (2003) Drug Info J , vol.37 , pp. 11-21
    • Atherton, P.J.1    Jasperson, B.2    Nibbe, A.3
  • 11
    • 40749105725 scopus 로고    scopus 로고
    • Graphical approaches to the analysis of safety data from clinical trials
    • Amit O, Heiberger RM, Lane PW Graphical approaches to the analysis of safety data from clinical trials. Pharm Stat 2008, 7:20-35.
    • (2008) Pharm Stat , vol.7 , pp. 20-35
    • Amit, O.1    Heiberger, R.M.2    Lane, P.W.3
  • 13
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004, 22:23-30.
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3
  • 14
    • 0034676813 scopus 로고    scopus 로고
    • Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
    • Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000, 356:2059-2063.
    • (2000) Lancet , vol.356 , pp. 2059-2063
    • Loprinzi, C.L.1    Kugler, J.W.2    Sloan, J.A.3
  • 15
    • 33751103252 scopus 로고    scopus 로고
    • Applying QOL assessments: solutions for oncology clinical practice and research, part 1
    • Sloan JA, Dueck AC, Frost MH, et al. Applying QOL assessments: solutions for oncology clinical practice and research, part 1. Curr Prob Cancer 2005, 29:265-352.
    • (2005) Curr Prob Cancer , vol.29 , pp. 265-352
    • Sloan, J.A.1    Dueck, A.C.2    Frost, M.H.3
  • 16
    • 36048972049 scopus 로고    scopus 로고
    • Applying QOL assessments: solutions for oncology clinical practice and research, part 2
    • Sloan JA, Dueck AC, Frost MH, et al. Applying QOL assessments: solutions for oncology clinical practice and research, part 2. Curr Prob Cancer 2006, 30:233-332.
    • (2006) Curr Prob Cancer , vol.30 , pp. 233-332
    • Sloan, J.A.1    Dueck, A.C.2    Frost, M.H.3
  • 18
    • 33748446657 scopus 로고    scopus 로고
    • Adverse event reporting in publications compared with sponsor database for cancer clinical trials
    • Scharf O, Colevas AD Adverse event reporting in publications compared with sponsor database for cancer clinical trials. J Clin Oncol 2006, 24:3933-3938.
    • (2006) J Clin Oncol , vol.24 , pp. 3933-3938
    • Scharf, O.1    Colevas, A.D.2
  • 19
    • 84870720349 scopus 로고    scopus 로고
    • Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology
    • Basch E, Abernethy AP, Mullins CD, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012, 30:4249-4255.
    • (2012) J Clin Oncol , vol.30 , pp. 4249-4255
    • Basch, E.1    Abernethy, A.P.2    Mullins, C.D.3
  • 20
    • 80051715635 scopus 로고    scopus 로고
    • Electronic toxicity monitoring and patient-reported outcomes
    • Basch EM, Reeve BB, Mitchell SA, et al. Electronic toxicity monitoring and patient-reported outcomes. Cancer J 2011, 17:231-234.
    • (2011) Cancer J , vol.17 , pp. 231-234
    • Basch, E.M.1    Reeve, B.B.2    Mitchell, S.A.3
  • 21
    • 84921904953 scopus 로고    scopus 로고
    • Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
    • Di Maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol 2015, 33:910-915.
    • (2015) J Clin Oncol , vol.33 , pp. 910-915
    • Di Maio, M.1    Gallo, C.2    Leighl, N.B.3
  • 22
    • 84883855864 scopus 로고    scopus 로고
    • Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
    • Judson TJ, Bennett AV, Rogak LJ, et al. Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy. J Clin Oncol 2013, 31:2580-2585.
    • (2013) J Clin Oncol , vol.31 , pp. 2580-2585
    • Judson, T.J.1    Bennett, A.V.2    Rogak, L.J.3
  • 23
    • 36849028533 scopus 로고    scopus 로고
    • Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy
    • Basch E, Iasonos A, Barz A, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007, 25:5374-5380.
    • (2007) J Clin Oncol , vol.25 , pp. 5374-5380
    • Basch, E.1    Iasonos, A.2    Barz, A.3
  • 24
    • 84880656074 scopus 로고    scopus 로고
    • Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial
    • Pietanza MC, Basch EM, Lash A, et al. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J Clin Oncol 2013, 31:2004-2009.
    • (2013) J Clin Oncol , vol.31 , pp. 2004-2009
    • Pietanza, M.C.1    Basch, E.M.2    Lash, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.